Somerville Kurt F Raises Position in Danaher Corporation $DHR

Somerville Kurt F raised its holdings in shares of Danaher Corporation (NYSE:DHR) by 1.2% during the 2nd quarter, HoldingsChannel reports. The fund owned 79,376 shares of the conglomerate’s stock after acquiring an additional 962 shares during the quarter. Danaher comprises approximately 2.6% of Somerville Kurt F’s portfolio, making the stock its 17th biggest holding. Somerville Kurt F’s holdings in Danaher were worth $15,680,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. GHP Investment Advisors Inc. lifted its stake in shares of Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after buying an additional 99 shares in the last quarter. Sierra Ocean LLC lifted its stake in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after buying an additional 76 shares in the last quarter. Red Tortoise LLC lifted its stake in shares of Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after buying an additional 98 shares in the last quarter. Smallwood Wealth Investment Management LLC purchased a new position in shares of Danaher during the 1st quarter valued at $31,000. Finally, Dunhill Financial LLC lifted its stake in shares of Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after buying an additional 67 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the business’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. The trade was a 11.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 11.20% of the stock is currently owned by company insiders.

Danaher Stock Down 1.5%

Shares of DHR stock opened at $208.63 on Wednesday. The stock has a market cap of $149.39 billion, a P/E ratio of 44.39, a PEG ratio of 3.02 and a beta of 0.77. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.41. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The company’s fifty day simple moving average is $200.40 and its two-hundred day simple moving average is $197.32.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same period in the previous year, the firm posted $1.72 EPS. The business’s quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s payout ratio is 27.23%.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Bank of America lowered their target price on shares of Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research note on Monday, September 22nd. UBS Group lowered their target price on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research note on Wednesday, July 23rd. Wells Fargo & Company decreased their price target on shares of Danaher from $210.00 to $205.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 23rd. Scotiabank upgraded shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target on the stock in a research note on Friday, July 11th. Finally, Evercore ISI boosted their price target on shares of Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research note on Tuesday. Seventeen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $246.74.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.